Pancrelipase
1551570
213333031
2008-05-18T21:39:47Z
Arcadian
104523
infobox
{{drugbox
|IUPAC_name=
|image=
|CAS_number=53608-75-6
|ATC_prefix=
|ATC_suffix=
|ATC_supplemental=
|PubChem=
|DrugBank=DB00085
|chemical_formula=C<sub>5850</sub>H<sub>8902</sub>N<sub>1606</sub>O<sub>1739</sub>S<sub>49</sub>
|molecular_weight=
|bioavailability=
|protein_bound=
|metabolism=
|elimination_half-life=
|excretion=
|pregnancy_AU=<!-- A / B1 / B2 / B3 / C / D / X -->
|pregnancy_US=<!-- A / B / C / D / X -->
|pregnancy_category=
|legal_AU=<!-- Unscheduled / S2 / S4 / S8 -->
|legal_UK=<!-- GSL / P / POM / CD -->
|legal_US=<!-- OTC / Rx-only -->
|legal_status=
|routes_of_administration=
}}
'''Pancrelipase''' is a form of [[enzyme]] therapy for the treatment of various digestive disorders, primarily [[Exocrine pancreatic insufficiency]]. It is a mixture of three digestive enzymes, [[amylase]], [[protease]] ([[peptidase]]), and [[lipase]], which are normally produced by the [[pancreas]]. Pancrelipase is used by people with [[cystic fibrosis]] whose pancreatic ducts are blocked with mucus. The blockage prevents digestive enzymes that are made by the pancreas from reaching the intestines, where they are needed for digestion. This is also used with people with [[Chronic pancreatitis]].
{{treatment-stub}}
[[Category:Enzymes]]